Hand-voetsyndroom
Geneesmiddelen waarbij Hand-voetsyndroom kan optreden
| Geneesmiddel | Werkzame stof | Frequentie |
|---|---|---|
| 5-fluoro-uracil (systemisch) | 5-fluoro-uracil (systemisch) | Vaak |
| afatinib | afatinib | Vaak |
| atezolizumab | atezolizumab | Vaak |
| avapritinib | avapritinib | Vaak |
| axitinib | axitinib | Vaak |
| bevacizumab (intraveneus) | bevacizumab (intraveneus) | Vaak |
| binimetinib | binimetinib | Vaak |
| bortezomib | bortezomib | Zelden |
| cabozantinib | cabozantinib | Vaak |
| clofarabine | clofarabine | Vaak |
| dabrafenib | dabrafenib | Vaak |
| dacomitinib | dacomitinib | Vaak |
| dasatinib | dasatinib | Soms |
| daunorubicine/cytarabine | daunorubicine/cytarabine | Soms |
| docetaxel | docetaxel | Vaak |
| doxorubicine in gepegyleerde liposomen | doxorubicine in gepegyleerde liposomen | Vaak |
| encorafenib | encorafenib | Vaak |
| enfortumab vedotin | enfortumab vedotin | Vaak |
| eribuline | eribuline | Vaak |
| erlotinib | erlotinib | Zelden |
| folinezuur (systemisch) | folinezuur (systemisch) | Vaak |
| irinotecan in gepegyleerde liposomen | irinotecan in gepegyleerde liposomen | Vaak |
| lenvatinib | lenvatinib | Vaak |
| mitomycine | mitomycine | Vaak |
| nilotinib | nilotinib | Zelden |
| osimertinib | osimertinib | Vaak |
| oxaliplatine | oxaliplatine | Vaak |
| panitumumab | panitumumab | Vaak |
| pazopanib | pazopanib | Vaak |
| ramucirumab | ramucirumab | Vaak |
| ripretinib | ripretinib | Vaak |
| rucaparib | rucaparib | Vaak |
| sorafenib | sorafenib | Vaak |
| sunitinib | sunitinib | Vaak |
| tegafur/gimeracil/oteracil | tegafur/gimeracil/oteracil | Vaak |
| tivozanib | tivozanib | Vaak |
| trametinib | trametinib | Vaak |
| trastuzumab | trastuzumab | Vaak |
| trastuzumab-emtansine | trastuzumab-emtansine | Vaak |
| trifluridine/tipiracil | trifluridine/tipiracil | Soms |
| vandetanib | vandetanib | Vaak |
| vemurafenib | vemurafenib | Vaak |